|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.210 CNY | +0.84% |
|
-1.64% | -16.55% |
| Market Cap | 3.68B 543M 475M 438M 405M 768M 51.79B 781M 5.23B 2.06B 25.51B 2.04B 1.99B 87.71B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.2B 472M 413M 381M 352M 668M 45.05B 679M 4.55B 1.79B 22.19B 1.77B 1.74B 76.3B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
34.06% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | +0.84% | ||
| 1 week | -1.64% | ||
| Current month | +5.87% | ||
| 1 month | -2.70% | ||
| 3 months | -16.84% | ||
| 6 months | -17.88% | ||
| Current year | -16.55% |
| 1 week | 7.04 | 7.5 | |
| 1 month | 6.63 | 7.73 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.85 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 2022-04-05 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 2022-12-01 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 2018-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Guo Xian Bao
BRD | Director/Board Member | 71 | 2022-05-11 |
Xin Min Zhao
BRD | Director/Board Member | 56 | 2020-01-01 |
Wen Bo Su
CHM | Chairman | 60 | 2014-05-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.84% | -1.64% | -14.57% | -38.27% | 543M | ||
| +0.95% | -0.08% | -12.82% | -8.16% | 12.85B | ||
| +2.42% | +1.37% | -33.43% | -54.80% | 4.79B | ||
| -0.02% | -0.64% | -6.89% | -5.76% | 4.4B | ||
| -7.84% | -7.31% | +12.48% | -9.74% | 3.68B | ||
| +2.11% | -0.70% | +4.02% | -37.69% | 3.82B | ||
| -0.58% | +6.63% | -8.69% | -13.03% | 3.26B | ||
| +0.28% | +0.57% | -11.39% | +2.92% | 3.1B | ||
| -0.77% | +1.24% | -7.85% | -23.20% | 2.41B | ||
| -0.32% | +4.78% | -5.40% | +44.70% | 1.8B | ||
| Average | -0.29% | -1.34% | -8.45% | -14.30% | 4.07B | |
| Weighted average by Cap. | -0.00% | -1.29% | -9.69% | -14.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 145M 126M 117M 108M 204M 13.79B 208M 1.39B 547M 6.79B 543M 531M 23.35B | 916M 135M 118M 109M 101M 191M 12.88B 194M 1.3B 511M 6.34B 507M 496M 21.81B |
| Net income | 60.07M 8.86M 7.75M 7.15M 6.6M 12.53M 845M 12.74M 85.4M 33.54M 416M 33.26M 32.54M 1.43B | 49.21M 7.26M 6.35M 5.86M 5.41M 10.26M 692M 10.43M 69.96M 27.47M 341M 27.25M 26.66M 1.17B |
| Net Debt | -357M -52.67M -46.07M -42.49M -39.25M -74.47M -5.02B -75.72M -508M -199M -2.47B -198M -193M -8.51B | -479M -70.64M -61.79M -57M -52.64M -99.89M -6.74B -102M -681M -267M -3.32B -265M -259M -11.41B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | CN¥7.210 | +0.84% | 3,801,500 |
| 26-07-09 | CN¥7.150 | -0.69% | 2,444,478 |
| 26-07-08 | CN¥7.200 | +0.28% | 2,672,619 |
| 26-07-07 | CN¥7.180 | -3.62% | 3,564,700 |
| 26-07-06 | CN¥7.450 | +1.64% | 4,054,200 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















